Klaria and RTHS begin collaboration on early migraine detection and treatment
Klaria Pharma Holding AB and RTHS AB are beginning a collaboration to investigate whether migraine attacks can be identified through changes in blood flow dynamics.

Announcements from RTHS AB. For interviews, imagery or technical detail, write to us and we will come back to you.
Klaria Pharma Holding AB and RTHS AB are beginning a collaboration to investigate whether migraine attacks can be identified through changes in blood flow dynamics.
Write to info@rthsscanner.com and mark it for press. Logotypes and imagery are available on request.